Newsfeed : Early ARV Treatment Is Cost-Effective in Poor Countries

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
E-newsletters
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Newsfeed » September 2011

Most Popular Links
Most Popular Lessons

The HIV Life Cycle

Shingles

Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV

15 Years Ago In POZ


More News

Click here for more news

Have news about HIV? Send press releases, news tips and other announcements to news@poz.com.


emailprint

September 21, 2011

Early ARV Treatment Is Cost-Effective in Poor Countries

New research shows that early antiretroviral (ARV) therapy is cost-effective in resource-poor countries like Haiti, according to a statement from Weill Cornell Medical College, which led the research. In 2009, the World Health Organization (WHO) altered its guidelines to recommend starting ARVs when CD4 cell counts fell below 350; previous guidelines suggested waiting till 200. The updated recommendation places more people on meds. Many donors and governments have hesitated following the guidelines because of budget and logistical challenges. The study was conducted by Weill Cornell Medical College, Groupe Haitien d’Etude du Sarcome de Kaposi et des Infections Opportunistes (GHESKIO) and Brigham and Women’s Hospital. Study results were published in PLoS Medicine.

To read the Weill Cornell statement, click here.

Search: World Health Organization, Weill Cornell Medical College, Haiti, cost-effective, resource-poor countries, Groupe Haitien d’Etude du Sarcome de Kaposi et des Infections Opportunistes, GHESKIO, Brigham and Women’s Hospital, ART, early ART


Scroll down to comment on this story.



Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The POZ team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules



Show comments (0 total)

 
[Go to top]

Join POZ Facebook Twitter Google+ MySpace YouTube Tumblr Flickr
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar


    charliehunter
    San Francisco
    California


    juliar33
    brooklyn
    New York


    Fred9774
    Brooklyn
    New York


    HOTROD2010
    houston
    Texas
Click here to join POZ Personals!
Ask POZ Pharmacist

Talk to Us
Poll
Will decriminalizing injection drug use help end the global HIV epidemic?
Yes
No

Survey
PrEP Course

more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2014 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.